title: Modeling & Informatics at Vertex Pharmaceuticals Incorporated: our philosophy for sustained impact.
abstract: Molecular modelers and informaticians have the unique opportunity to integrate cross-functional data using a myriad of tools, methods and visuals to generate information. Using their drug discovery expertise, information is transformed to knowledge that impacts drug discovery. These insights are often times formulated locally and then applied more broadly, which influence the discovery of new medicines. This is particularly true in an organization where the members are exposed to projects throughout an organization, such as in the case of the global Modeling & Informatics group at Vertex Pharmaceuticals. From its inception, Vertex has been a leader in the development and use of computational methods for drug discovery. In this paper, we describe the Modeling & Informatics group at Vertex and the underlying philosophy, which has driven this team to sustain impact on the discovery of first-in-class transformative medicines.
authors.affiliation: Vertex Pharmaceuticals Inc., Boston, MA, USA. georgia_mcgaughey@vrtx.com.
authors.forename: Georgia
authors.identifier: 0000-0002-3586-965X
authors.initials: G
authors.lastname: McGaughey
authors.affiliation: Relay Therapeutics, Cambridge, MA, USA.
authors.forename: W
authors.initials: W
authors.lastname: Patrick Walters
mesh_terms: D002626:Chemistry, Pharmaceutical; D019295:Computational Biology; D017076:Computer-Aided Design; D015195:Drug Design; D055808:Drug Discovery; D004345:Drug Industry / Q000379:methods*; D008958:Models, Molecular; D012984:Software; D013329:Structure-Activity Relationship
keywords: Cheminformatics; Computational chemistry; Modeling